Prof. Javed Iqbal
Prof Iqbal graduated from Delhi University and worked as a scientist at Ranbaxy Laboratories, New Delhi and subsequently worked as an SERC post-doctoral fellow at Cambridge University in the research group of Prof Ian Fleming, FRS. He later moved to Oxford University and worked as a research fellow with Prof J. E. Baldwin, FRS. He was a Professor at IIT Kanpur during 1984-99 and subsequently moved to Dr Reddy’s Laboratories Ltd (DRL), Hyderabad where he served as Distinguished Research Scientist and Global Head, Discovery Chemistry during 2000-07. Subsequently, he was Director of Dr Reddy’s Institute of Life Sciences, Hyderabad during 2007-20013.
He has contributed significantly on new drug discovery in area of diabetes, cancer and infectious diseases. His research activities at DRL involved design and synthesis of small molecules to modulate disease targets like PPAR, AMPK, JNK, Raf and Aurora kinases. Two of the drugs discovered by his group at Dr. Reddy’s Laboratories Ltd (DRL) were taken into phase I clinical trials in Canada and UK. He has guided 30 PhD students and has published more than 200 research papers and has filed 135 patents in area of diabetes, infectious diseases, cancer, process chemistry for API’s and pharmaceutical co-crystals.
Prof Iqbal is the promoter of two startups called Cosmic Discoveries and Zephase Therapeutics. Cosmic Discoveries has developed process chemistry for 40-50 drug molecules and intermediates. He has recently founded a company called Cosmic Therapeutics which is focused on R&D and manufacturing of drug intermediates and APIs which has a strategic partnership with Curiolex Limited, Shanghai, China.
He has also served as Director of Regional Research Laboratory (CSIR) Trivandrum during 2002. He was visiting fellow at University of Notre Dame, USA, University of Montpellier, France and University of Okayama, Japan. Prof Iqbal has also taught undergraduate Chemistry Courses at New Mexico State University, Las Cruces, USA in the summer semesters during 1997-99. He was William Evans Fellow in the Department of Chemistry, University of Otago, New Zealand during March-April, 2016.
Prof Iqbal is the fellow of both science academies of India and was member of IUPAC committee on Chemicals and Drugs and now a fellow of IUPAC. He is a member of Prime Minister’s committee on CSIR society and is a member of Ministry of Science and Technology’s committee, Government of India on Drugs and Pharmaceuticals.
He is on the international advisory board of medicinal chemistry journal CHEMMEDCHEM published by Wiley-VCH and represents India as member of Regional committee on Asia and Pacific (RCAP) of International council of Science (ICSU) Kuala Lumpur, Malaysia and is Chair, Science planning group on Epigenitics of RCAP, ICSU Kuala Lumpur, Malaysia.
He is on the board of Loka Biosciences, Hyderabad and is currently founder Chairman of Cosmic Therapeutics, Hyderabad and Chief Scientific Advisor to Calyx Chemicals and Pharmaceuticals, Mumbai, Scientific Advisor, Stereokem Pharma, Hyderabad and Kreative Organics Private Limited, Hyderabad.
He is also a Pharma Consultant and has worked with ICICI Venture and IMS health and has conducted scientific due-diligence on their behalf of Sai Life Sciences, Hyderabad and Neuland Laboratories, Hyderabad. He is currently Scientific Advisor to CSIR- Indian Institute of Chemical Technology, Hyderabad on their Drugs and Pharmaceutical Program. He has recently become scientific advisor to a biotech company, Proteorex Therapeutics based at Toronto, Canada.